Provided by Tiger Fintech (Singapore) Pte. Ltd.

BEIGENE

151.300
+11.6008.30%
Volume:5.78M
Turnover:855.09M
Market Cap:211.97B
PE:-41.40
High:153.100
Open:140.200
Low:140.200
Close:139.700
Loading ...

BeiGene Ltd BeiGene Q4 Net Loss Narrows, Revenue Rises; 2025 Revenue Guidance Set

MT Newswires Live
·
27 Feb

BeiGene Expects 2025 Total Revenue Of $4.9B-$5.3B Versus $3.81B YoY

Benzinga
·
27 Feb

BeiGene Q4 2024 GAAP EPADS $(1.43) Up From $(3.53) YoY, Sales $1.13B Versus $634.41M YoY

Benzinga
·
27 Feb

Nomura Adjusts BeiGene Price Target to $316.65 From $293.78, Maintains Buy Rating

MT Newswires Live
·
18 Feb

Nomura Adjusts BeiGene's Price Target to HK$188.53 From HK$174.91, Keeps at Buy

MT Newswires Live
·
18 Feb

BeiGene, Ltd. (NASDAQ:ONC) Stock Catapults 26% Though Its Price And Business Still Lag The Industry

Simply Wall St.
·
06 Feb

BeiGene Grants ADS Options, Units to Employees Under Incentive Schemes

MT Newswires Live
·
03 Feb

ImmunityBio Shares Rise After Collaboration, Supply Agreement With BeiGene

Dow Jones
·
29 Jan

ImmunityBio Partners With BeiGene to Conduct Phase 3 Trial of Lung Cancer Combination Therapy

MT Newswires Live
·
29 Jan

BeiGene Stock Meets 80-Plus RS Rating Benchmark

Blockhead
·
16 Jan

Is BeiGene (NASDAQ:ONC) A Risky Investment?

Simply Wall St.
·
14 Jan

BUZZ-Beigene's HK shares jump most in 2 years on 'positive' earnings outlook

Reuters
·
14 Jan

Stock Track | BeiGene Soars Nearly 7% as Company Forecasts Positive Operating Income for 2025

Stock Track
·
14 Jan

BeiGene Forecasts 'Positive Operating Income' in 2025; Hong Kong Shares Rise 5%

MT Newswires Live
·
14 Jan

JPMorgan Chase & Co's Short Position in Beigene Decreases to 0.69% on Jan 3 From 1.35% - HKEX

THOMSON REUTERS
·
09 Jan

JPMorgan Chase & Co's Long Position in Beigene Decreases to 9.83% on Jan 3 From 10.33% - HKEX

THOMSON REUTERS
·
09 Jan

MAIA Biotechnology Shares Rise After Supply Agreement With BeiGene

Dow Jones
·
08 Jan

BeiGene Gets FDA Approval for Tevimbra in Stomach-Esophagus Junction Cancer

MT Newswires Live
·
27 Dec 2024

BeiGene Stomach-Cancer Treatment Gets FDA Approval, Second in U.S.

Dow Jones
·
27 Dec 2024

BeiGene to Change Ticker Symbol to 'ONC', Reflecting Oncology Commitment

MT Newswires Live
·
23 Dec 2024